Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera

WorldMEN (17th International Workshop on Multiple Endocrine Neoplasia and other Rare Endocrine Tumors)

Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive (JFHOD)

114ème Congrès Français d’Urologie

23rd European Congress of Endocrinology (ECE)

American Society of Clinical Oncology (ASCO) Annual Meeting

Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

ESMO (European Society for Medical Oncology) Congress

34th Annual Congress of the European Association of Nuclear Medicine (EANM)

NANETS (North American Neuroendocrine Tumor Society) Symposium